Peringkat dalam Saham
#38667
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
Harga Saham
$0.04057595
Terakhir disinkronkan: 2024-08-05
Kapitalisasi Pasar
$863.62K
Perubahan (1 tahun)
0.00%
Perdagangan AegirBio AB (publ) (AEGIR)
Harga AEGIR dengan kapitalisasi pasar B
Kapitalisasi pasar dari AegirBio AB (publ)(AEGIR)
Kapitalisasi Pasar: $863.62K
Per August 2026, AegirBio AB (publ) memiliki kapitalisasi pasar sebesar $863.62K. Ini menjadikan AegirBio AB (publ) sebagai perusahaan 38667th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar AegirBio AB (publ) dari 2020 hingga 2026
AEGIR dibandingkan dengan 5 teratas stocks paling populer
| Harga AEGIR |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.453T
|
+631,443,155.87%
|
|
|
|
|
$4.486T
|
+519,447,649.56%
|
|
|
|
|
$4.159T
|
+481,603,306.32%
|
|
|
|
|
$3.691T
|
+427,415,543.88%
|
|
|
|
|
$2.843T
|
+329,196,823.83%
|
